[11] The absence of severe hypoglycemia is consistent with the glucose-dependent insulinotropic mechanism of GLP-1 receptor agonists. The rates of confirmed hypoglycemia were similar between the ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Recently, GLP-1 receptor agonist medications have been prescribed more commonly, in part due to their ability to ...

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...

Recent findings have proposed the combination of two agonist mechanisms – glucagon-like peptide 1 (GLP-1) and fibroblast growth factor 21 (FGF21) – to have a synergistic effect for the treatment of ...

In patients with type 2 diabetes, GLP-1 receptor agonists and SGLT2 inhibitors have similar kidney and cardiovascular outcomes. Similar kidney and cardiovascular outcomes are found with glucagon-like ...

However, its overall safety profile was comparable to that of GLP-1 receptor agonists, with no elevated risk for pancreatic-biliary adverse events, diabetic retinopathy, or medullary thyroid cancer.

Natural supplements have “very mild effects” on weight loss based on what Dr. Ali has seen. There is some data to suggest ...

In metabolic dysfunction-associated steatotic liver disease, a retrospective analysis shows that patients on GLP-1 receptor ...

Why Trust Us? GLP-1 receptor agonists like Ozempic and Wegovy have a lot of scientific data to support their use—and they can help people drop a lot of pounds. But is it possible to get the same ...